Related Experiment Video
Updated: Jun 26, 2026

Rapid Isolation of the Mitoribosome from HEK Cells
Published on: October 4, 2018
Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside
Sven N Hobbie1, Subramanian Akshay, Sarath K Kalapala
1Institut für Medizinische Mikrobiologie, Universität Zürich, Gloriastrasse 32, CH-8006 Zurich, Switzerland.
Abstract:
Aminoglycoside ototoxicity has been related to a surprisingly large number of cellular structures and metabolic pathways. The finding that patients with mutations in mitochondrial rRNA are hypersusceptible to aminoglycoside-induced hearing loss has indicated a possible role for mitochondrial protein synthesis. To study the molecular interaction of aminoglycosides with eukaryotic ribosomes, we made use of the observation that the drug binding site is a distinct domain defined by the small subunit rRNA, and investigated drug susceptibility of bacterial hybrid ribosomes carrying various alleles of the eukaryotic decoding site. Compared to hybrid ribosomes with the A site of human cytosolic ribosomes, susceptibility of mitochondrial hybrid ribosomes to various aminoglycosides correlated with the relative cochleotoxicity of these drugs. Sequence alterations that correspond to the mitochondrial deafness mutations A1555G and C1494T increased drug-binding and rendered the ribosomal decoding site hypersusceptible to aminoglycoside-induced mistranslation and inhibition of protein synthesis. Our results provide experimental support for aminoglycoside-induced dysfunction of the mitochondrial ribosome. We propose a pathogenic mechanism in which interference of aminoglycosides with mitochondrial protein synthesis exacerbates the drugs' cochlear toxicity, playing a key role in sporadic dose-dependent and genetically inherited, aminoglycoside-induced deafness.
Insights
Aminoglycoside antibiotics can cause hearing loss by interfering with mitochondrial protein synthesis. Specific mutations increase susceptibility, highlighting the mitochondrial ribosome
Area of Science:
- Molecular Biology
- Genetics
- Ototoxicology
Background:
- Aminoglycoside ototoxicity is linked to cellular structures and metabolic pathways.
- Mutations in mitochondrial ribosomal RNA (rRNA) increase susceptibility to aminoglycoside-induced hearing loss, suggesting a role for mitochondrial protein synthesis.
Purpose of the Study:
- To investigate the molecular interaction of aminoglycosides with eukaryotic ribosomes.
- To understand the role of the mitochondrial ribosome in aminoglycoside-induced hearing loss.
Main Methods:
- Constructed bacterial hybrid ribosomes with eukaryotic decoding sites, including mitochondrial and cytosolic variants.
- Assessed the susceptibility of these hybrid ribosomes to various aminoglycosides.
- Analyzed sequence alterations corresponding to known mitochondrial deafness mutations (A1555G, C1494T).
Main Results:
- Mitochondrial hybrid ribosomes showed susceptibility correlating with drug cochleotoxicity.
- Mutations A1555G and C1494T increased aminoglycoside binding and hypersusceptibility.
- These mutations led to aminoglycoside-induced mistranslation and inhibited protein synthesis in the mitochondrial ribosome.
Conclusions:
- Aminoglycosides can directly cause dysfunction of the mitochondrial ribosome.
- Interference with mitochondrial protein synthesis exacerbates cochlear toxicity, contributing to aminoglycoside-induced deafness.
- This mechanism is relevant for both sporadic and inherited forms of hearing loss.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Translational Regulation
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...

